DHA Clinical Pharmacy Course: Disease State Management

Program Description: 

This course of the DHA Clinical Pharmacy Course centers on Disease State Management.

The recordings in this module include:

  • DHA CPC: Antibiotic Stewardship
  • DHA CPC: Anticoagulation: Warfarin: Initiation, Monitoring, and Bridging; DOACs: Balancing Bleeds and Weight Extremes
  • DHA CPC: Pharmacogenomics: The Foundation
  • DHA CPC: Contraceptive Management
  • DHA CPC: Pharmacogenomics in Mental Health
  • DHA CPC: Medication Management for Bariatric Surgery
  • DHA CPC: Menopause and Female Sexual Dysfunction
  • DHA CPC: 2024 Diabetes Updates
  • DHA CPC: Drug Therapy for Obesity Management
  • DHA CPC: Infectious Disease Review for the Ambulatory Care Pharmacist
  • DHA CPC: Continuous Glucose Monitors

To access the video(s) on the Clinical Pharmacy SharePoint site, please use your CAC-enabled government computer to copy the following link and paste it in your browser's address bar:

https://militaryhealth.sharepoint-mil.us/:f:/r/teams/POD_PharmacyOperationsDivisionPublic/Shared Documents/Clinical Pharmacy Community/2024 Clinical Pharmacy Course Home Study Program --DO NOT DELETE--?csf=1&web=1&e=wpQpmk

The videos are available to learners within the Defense Health Administration network. If you have difficulty accessing the recording (s) for this session, then please email Dawn Soulati ([email protected]).

Target Audience

This activity provides continuing education for pharmacists and pharmacy technicians. A certificate of attendance is available for other attendees.

Learning Objectives

  1. Describe antibiotic prescribing trends in the United States.
  2. List the core elements of antimicrobial stewardship programs (ASPs).
  3. Outline where to access antimicrobial stewardship resources.
  4. Decide which patients require warfarin over direct-acting oral anticoagulants (DOACs).
  5. Determine outpatient management of venous thromboembolism (initiation, follow up, duration).
  6. Describe appropriate transition to and from warfarin and its application before and after procedures.
  7. Explain the pharmacogenomics (PGx) field
  8. Describe pharmacokinetic/pharmacodynamics principles and application to drug absorption, distribution, metabolism and elimination (ADME) involved in PGx
  9. Describe the role of the provider in both preconception and contraception care.
  10. Review contraceptives available.
  11. Outline current guidelines for contraceptive management.
  12. Describe the evidence of pharmacogenomics in mental health (MH) prescribing.
  13. Summarize the types of bariatric surgery and candidates for bariatric surgery.
  14. Explain the clinical pharmacists’ role in bariatric medication management.
  15. Evaluate medication management for certain chronic disease states such as hypertension, diabetes, and hyperlipidemia in patient pre/post-bariatric surgery.
  16. Review female reproductive life cycle.
  17. Describe the role of the provider in treatment of genitourinary syndrome of menopause (GSM) and vulvovaginal atrophy (VVA).
  18. Outline current guidelines for treatment of menopause symptoms.
  19. Review pharmacotherapy treatments for female sexual dysfunction.
  20. Review diagnosis criteria for Diabetes.
  21. Identify cardiorenal risk factors to determine appropriate medications for patients with T2DM.
  22. Determine glycemic and HgA1c goals based on age and comorbid conditions.
  23. Describe specific goals for older adults, children and adolescents.
  24. Evaluate the current evidence supporting use of each class of anti-obesity medication.
  25. Apply a weight loss management plan incorporating lifestyle intervention and pharmacotherapy for a patient who is a candidate for anti-obesity medication.
  26. Recall infectious disease states for which antimicrobial therapy is not commonly recommended
  27. Summarize various antibiotic therapy for infectious diseases in the ambulatory care setting for adult patients
  28. Compare and contrast continuous glucose monitoring technologies.
  29. Identify appropriate candidates and optimize use of continuous glucose monitors (CGMs).
Course summary
Available credit: 
  • 14.00 Pharmacists (ACPE)
    UAN: JA4008136-0000-25-030-H01-P
    No valid paper/electronic statement of credit will be offered. DHA, J-7, CEPO is accredited by the American Council for Pharmacy Education (ACPE) to provide continuing education for Pharmacists. This knowledge based activity will provide a maximum of 14.00 contact hours of pharmacy continuing education credit. Participant CE records will be electronically communicated to CPE Monitor. There is no cost to participate in this activity.
  • 14.00 Pharmacy Technicians (ACPE)
    UAN: JA4008136-0000-25-030-H01-T
    No valid paper/electronic statement of credit will be offered. DHA, J-7, CEPO is accredited by the American Council for Pharmacy Education (ACPE) to provide continuing education for Pharmacy Technicians. This knowledge based activity will provide a maximum of 14.00 contact hours of pharmacy continuing education credit. Participant CE records will be electronically communicated to CPE Monitor. There is no cost to participate in this activity.
  • 14.00 Certificate of Attendance
Course opens: 
03/17/2025
Course expires: 
06/06/2025
Part of: 
DHA Clinical Pharmacy Course

Stephanie Giancola, Pharm.D., B.C.P.S., B.C.I.D.P. Presenter has no financial or non-financial relationships to disclose.
Becky Briar, B.S.Pharm., Pharm.D., B.C.A.C.P., C.A.C.P., T.T.S. Presenter has no financial or non-financial relationships to disclose.
Janel Rossetto Pharm.D., M.S., B.C.N.S.P. Presenter has no financial or non-financial relationships to disclose.
Sarah Abel, Pharm.D., M.S.C.P., C.C.S.P. Presenter has no financial or non-financial relationships to disclose.
Rachael Coller, Pharm.D., B.C.P.S., B.C.P.P. Presenter has no financial or non-financial relationships to disclose.
Jennifer Kim, Pharm.D., B.C.A.C.P., B.C.A.D.M. Presenter has no financial or non-financial relationships to disclose. Dr. Kim will discuss off-label uses for the following medications: bupropion (Actavis), naltrexone (Accord), topiramate (Par)
Kelly Campbell, Pharm.D., B.C.P.S. Presenter has no financial or non-financial relationships to disclose. Dr. Campbell will discuss off-label uses for individual components of Qsymia and Contrave for weight management
Jacqueline Merritt, Pharm.D. Presenter has no financial or non-financial relationships to disclose.
Azra Khan, Pharm.D., B.C.A.C.P., C.D.C.E.S. Presenter has no financial or non-financial relationships to disclose.
Kayla Scheps, Pharm.D., B.C.I.D.P., M.B.A. Presenter has no financial or non-financial relationships to disclose.
Megan Urias, Pharm.D., B.C.P.S. Presenter has no financial or non-financial relationships to disclose.
Mayce Vinson, Pharm.D., B.C.-A.D.M. Presenter has no financial or non-financial relationships to disclose.
Tabitha K. Oliver, Pharm.D., B.C.A.C.P., B.C.-A.D.M. Presenter has no financial or non-financial relationships to disclose.

Disclosure: DHA J-7 staff, planning committee members, and content reviewers have no financial interest to disclose.

Available Credit

  • 14.00 Pharmacists (ACPE)
    UAN: JA4008136-0000-25-030-H01-P
    No valid paper/electronic statement of credit will be offered. DHA, J-7, CEPO is accredited by the American Council for Pharmacy Education (ACPE) to provide continuing education for Pharmacists. This knowledge based activity will provide a maximum of 14.00 contact hours of pharmacy continuing education credit. Participant CE records will be electronically communicated to CPE Monitor. There is no cost to participate in this activity.
  • 14.00 Pharmacy Technicians (ACPE)
    UAN: JA4008136-0000-25-030-H01-T
    No valid paper/electronic statement of credit will be offered. DHA, J-7, CEPO is accredited by the American Council for Pharmacy Education (ACPE) to provide continuing education for Pharmacy Technicians. This knowledge based activity will provide a maximum of 14.00 contact hours of pharmacy continuing education credit. Participant CE records will be electronically communicated to CPE Monitor. There is no cost to participate in this activity.
  • 14.00 Certificate of Attendance
Please login or create an account to take this course.



Requirements: CE/CME certificates are awarded to participants who fully complete the activity, successfully submit the evaluation survey, and pass the posttest. The deadline to claim credit is Jun 6, 2025.

Access Code: Some activities require an access code to register or claim credit. Please contact the organization providing the activity for the access code. The Continuing Education Program Office (CEPO) does not provide access codes.

Accommodations: Please contact the course instructor to inquire about accommodations. For additional technical support, email [email protected].